Last updated: 2026-09-30 20:03:20. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $265.01, with a market capitalization of $655.37B and a P/E ratio of 30.65. Over the past 52 weeks, its price has ranged from $181.07 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$655.37B | |
$267.91 | |
$281.07 | |
$46.25 | |
$267.57 | |
3.45M | |
6.98M | |
30.65 | |
$281.07 | |
$181.07 | |
1.96% | |
-- |
Johnson & Johnson (JNJ) is trading at $265.14 in after-hours trading as of 2026-09-30 19:46:59, down 0.91% ($2.44) from the regular-session close of $267.57.
After-hours trading shows how investors are pricing JNJ after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.
Over the past seven days, Johnson & Johnson (JNJ) moved from $269.47 to $265.01, representing a decline of 1.66% ($4.46).
The stock traded between $264.62 and $275.23 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 5.72 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 83.9%
JNJ is currently trading at $265.01, placing it 83.9% of the way from its 52-week low of $181.07 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.